⌘K

Login Start Free

Home/Filings/4/0001209191-22-018153

4//SEC Filing

Virgin Herbert 4

Accession 0001209191-22-018153

CIK 0001706431other

View on SEC.gov Company Profile

Filed

Mar 10, 7:00 PM ET

Accepted

Mar 11, 4:04 PM ET

Size

6.9 KB

Accession

0001209191-22-018153

Insider Transaction Report

Form 4

Period: 2022-03-10

Vir Biotechnology, Inc.VIR

EVP, Research & CSO

Transactions

Exercise/Conversion
Common Stock
2022-03-10$1.53/sh+9,000$13,770→ 184,407 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-03-10−9,000→ 210,505 total
Exercise: $1.53Exp: 2028-01-26→ Common Stock (9,000 underlying)

Footnotes (1)

[F1]The option is fully vested and exercisable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1

filerCIK 0001786378

Filing Metadata

Form type: 4
Filed: Mar 10, 7:00 PM ET
Accepted: Mar 11, 4:04 PM ET
Size: 6.9 KB

View on SEC.gov